|
KIAA0146 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.595900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.06180000000323E-05 |
| Normal-vs-Stage2 |
1.607620E-02 |
| Normal-vs-Stage3 |
2.085900E-02 |
| Normal-vs-Stage4 |
1.059620E-01 |
| Stage1-vs-Stage2 |
2.254000E-01 |
| Stage1-vs-Stage3 |
3.949600E-01 |
| Stage1-vs-Stage4 |
5.594800E-01 |
| Stage2-vs-Stage3 |
8.896600E-01 |
| Stage2-vs-Stage4 |
9.473400E-01 |
| Stage3-vs-Stage4 |
9.774200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.592400E-04 |
| Normal-vs-AfricanAmerican |
1.162160E-03 |
| Normal-vs-Asian |
1.602750E-01 |
| Caucasian-vs-AfricanAmerican |
7.617200E-01 |
| Caucasian-vs-Asian |
9.590000E-01 |
| AfricanAmerican-vs-Asian |
8.779600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.86590000017928E-07 |
| Normal-vs-Female |
3.343000E-01 |
| Male-vs-Female |
3.55670000000696E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.224700E-03 |
| Normal-vs-Extreme_Weight |
3.71080000000079E-05 |
| Normal-vs-Obese |
6.516500E-03 |
| Normal-vs-Extreme_Obese |
1.944890E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.642400E-01 |
| Normal_Weight-vs-Obese |
6.581200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.842760E-01 |
| Extreme_Weight-vs-Obese |
1.158760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.184600E-01 |
| Obese-vs-Extreme_Obese |
9.172100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.120000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.229300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.226480E-04 |
| Normal-vs-Age(81-100Yrs) |
3.882900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.263960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.734490E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.574500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.544800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.700210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.827200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.61172999999515E-05 |
| Normal-VS-Type2 PRCC |
4.71719999950437E-07 |
| Normal-VS-KIRP CIMP |
6.763400E-01 |
| Normal-VS-Unclassified PRCC |
1.118160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.076300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.290200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.360100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.643960E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.818900E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.281430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.65329999999897E-05 |
| Normal-vs-N1 |
5.728600E-01 |
| Normal-vs-N2 |
5.492000E-01 |
| N0-vs-N1 |
1.054060E-02 |
| N0-vs-N2 |
1.097610E-01 |
| N1-vs-N2 |
8.122000E-01 |
|
|
